NCT05692180
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
Phase: Phase 3
Role: Collaborator
Start: Apr 5, 2023
Completion: May 16, 2032